Invest Value Analysis Based on Risk, Profit and Market

Authors

  • Haoyang Liu

DOI:

https://doi.org/10.54097/hbem.v13i.8813

Keywords:

Health sector stocks, invest value analysis, multiple-factor analytics.

Abstract

In 2022, the post-pandemic period, the health sector stocks had a big difference in price performance between different stocks. Some stocks rose significantly because of the vaccines and specific drugs for covid-19, while others' growth slowed down or even had negative profit margins because people were afraid to go to the hospital which cause a reduction of other drugs' sales volume. In the health sectors, there're companies that research and development of drugs, distribute drugs, make medical apparatus and instruments, and even have some "grocery stores" like CVS. It might be difficult to find which stocks are worth the cost of implementation in the post-pandemic period and the special increase because Covid-19 has ended. This paper will analyze 3 stocks as an example to show the investment decisions between different investors. By using risk analysis, profit analysis, and market analysis, this paper will show the investment value of 3 stocks: CVS, MCK, and WBA. These analyses are based on PE, PB, ROA, ROE, profit margin, and many other ratios in 2022. This article will help people choose the health sector stocks. In the conclusion, MCK has the most investment value in 2023 and MCK has a stable income with low risk. WBA may be a bad choice.

Downloads

Download data is not yet available.

References

CVS Health commits nearly $19 million for affordable housing development (2022). Corporate Philanthropy Report, 37(10), pp. 2-3.

O’Connor Mary I.. (2022). Equity360: Gender, Race, and Ethnicity—How Walmart, CVS, and Walgreens Are Disrupting Healthcare (and Promoting Health Equity). Clinical Orthopaedics & Related Research

Pang Ran (2022). The CVS annual report revealed these signals and commented that the revenue was nearly $300 billion! The CVS annual report was released China Pharmacy (03), 10. doi:

Wang Xuhan (2022). From the perspective of Rice's text typology theory, "The 2020 Corporate Social Responsibility Report of West Wes Health Company" (excerpt), an English-Chinese translation practice report (master's degree thesis, Tianjin University of Commerce)

Wu Xiaowei (2004). The success of Sears and cvs International Business Technology, 000 (002), 62-63.

Akiko Imai and Aiko Akiko and Akiko Imai. 2022. A study on the destructive innovation and competitive advantage of the U.S. pharmaceutical market: CVS health and Walmart 19 PP. 27-40.

John York et al. (2021). CVS health faces a new wave of disruption. International Journal of Pharmaceutical and Healthcare Marketing, 15(3), pp. 333-353.

Gao Hongyang (2021). CVS Health VS Wobo Union, the battle of Tianwang Mountain has come to an end China Pharmacy (03), 54-57. doi:

Gao Hongyang (2022). The world's top 500 companies were announced, and CVS Health led the drug retail market China Pharmacy (05), 90-92. doi:

McKesson Corporation (2019); McKesson and Genpact Expand Their Relationship to Support McKesson's Finance Operating Model Optimization. Information Technology Newsweekly

Healthcare Supply Chain Management Market Size, Status and Forecast 2025: Emerging Key players- Oracle Corporation, McKesson Corporation. M2 Presswire

McKesson Ventures Reports on New Partner Promotions (2020). Wireless News,

Walgreens Boots Alliance Rolls Out 2020 Corporate Social Responsibility Report (2021).. Manufacturing Close - Up,

Downloads

Published

29-05-2023